Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | VYBION : Antibody |
Description | Innovation in Vectorized About Vybion Business Strategy --> History --> Management Board of Directors Pipeline Technology Partnerships and Licensing Latest News Research & D |
Keywords | N/A |
WebSite | vybion.com |
Host IP | 64.57.176.36 |
Location | United States |
Site | Rank |
US$468,148
Last updated: 2023-05-10 14:30:30
vybion.com has Semrush global rank of 22,608,904. vybion.com has an estimated worth of US$ 468,148, based on its estimated Ads revenue. vybion.com receives approximately 54,018 unique visitors each day. Its web server is located in United States, with IP address 64.57.176.36. According to SiteAdvisor, vybion.com is safe to visit. |
Purchase/Sale Value | US$468,148 |
Daily Ads Revenue | US$433 |
Monthly Ads Revenue | US$12,965 |
Yearly Ads Revenue | US$155,570 |
Daily Unique Visitors | 3,602 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
vybion.com. | A | 3600 | IP: 64.57.176.36 |
vybion.com. | NS | 3600 | NS Record: sdn.iecc.com. |
vybion.com. | NS | 3600 | NS Record: light.lightlink.com. |
vybion.com. | NS | 3600 | NS Record: majesty.lightlink.com. |
vybion.com. | MX | 3600 | MX Record: 10 aspmx.l.google.com. |
vybion.com. | MX | 3600 | MX Record: 30 aspmx4.googlemail.com. |
vybion.com. | MX | 3600 | MX Record: 20 alt2.aspmx.l.google.com. |
vybion.com. | MX | 3600 | MX Record: 30 aspmx5.googlemail.com. |
vybion.com. | MX | 3600 | MX Record: 30 aspmx3.googlemail.com. |
vybion.com. | MX | 3600 | MX Record: 30 aspmx2.googlemail.com. |
vybion.com. | MX | 3600 | MX Record: 20 alt1.aspmx.l.google.com. |
vybion.com. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
About Vybion Business Strategy --> History --> Management Board of Directors Pipeline Technology Partnerships and Licensing Latest News Research & Diagnostics --> Biopharma Services --> Innovation in Vectorized Intrabodies. Vybion is the leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical needs. Vybion Intrabodies are scFv fragments that target and change the fate of intracellular events like the protein aggregation, gene dysregulation and turnover of toxic protein fragments as a disease modifying approach to therapeutics. LATEST NEWS: December 3rd, 2018 Vybion Receives Orphan Drug Designation for INT41 in Huntington’s Disease More» April 3rd, 2018 Patent Issues for Novel Huntington’s and Alzheimer’s Disease Gene Therapy... More» December 15th, 2017 Vybion gives invited presentation at annual virtual conference Emerging Medical Technologies Spotlight... More» November |
HTTP/1.1 200 OK Date: Tue, 02 Nov 2021 22:14:28 GMT Server: Apache/2.2.0 Content-Type: text/html; charset=ISO-8859-1 |
Domain Name: VYBION.COM Registry Domain ID: 234509924_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-10-16T14:13:45Z Creation Date: 2005-10-18T21:23:20Z Registry Expiry Date: 2021-10-18T21:23:20Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: LIGHT.LIGHTLINK.COM Name Server: MAJESTY.LIGHTLINK.COM Name Server: SDN.IECC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-25T08:49:14Z <<< |